The first Abiomed trade was made in Q3 2018.
Since then Sands Capital bought shares seven more times and sold shares on three occasions. The investor sold all their shares in Q1 2021 and doesn't own any shares in Abiomed anymore.
Avg closing price
Price range
Sold -2.96 Million shares
Q1 2021
Avg closing price
$320.02
Price range
$285.92
-
$355.13
Increased shares by 98.0% (+1.46 Million shares)
Q4 2020
Avg closing price
$276.60
Price range
$251.88
-
$324.20
Increased shares by 2.1% (+30.5 Thousand shares)
Q3 2020
Avg closing price
$288.09
Price range
$255.22
-
$317.00
Increased shares by 0.2% (+3.61 Thousand shares)
Q2 2020
Avg closing price
$200.79
Price range
$141.40
-
$257.09
Sold 40.2% shares (-980 Thousand shares)
Q1 2020
Avg closing price
$166.01
Price range
$130.51
-
$196.01
Increased shares by 25.8% (+500 Thousand shares)
Q4 2019
Avg closing price
$185.40
Price range
$159.31
-
$223.54
Sold 9.2% shares (-196 Thousand shares)
Q3 2019
Avg closing price
$216.16
Price range
$175.89
-
$279.23
Increased shares by 64.2% (+835 Thousand shares)
Q2 2019
Avg closing price
$265.32
Price range
$250.96
-
$284.94
Increased shares by 52.7% (+449 Thousand shares)
Q1 2019
Avg closing price
$332.35
Price range
$276.39
-
$362.25
Increased shares by 92.1% (+409 Thousand shares)
Q4 2018